JRCT ID: jRCTs021190011
Registered date:13/11/2019
SWORD C Study
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | irritable bowel syndrome |
Date of first enrollment | 07/07/2020 |
Target sample size | 68 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | A: Yokukansankachimpihange 7.5 g per day for 12 weeks B: Potato starch 7.5 g per day for 12 weeks |
Outcome(s)
Primary Outcome | Change from baseline in outcome of STAI State Anxiety Inventory score at 12weeks |
---|---|
Secondary Outcome | 1. STAI Trait Anxiety Inventory score 2. HADS score 3. IBS-QOL score 4. Daily number of stools 5. Stool consistency 6. Abdominal pain severity, abdominal fullness, anxiety score 7. Improvement rates of abdominal pain severity, abdominal fullness, Anxiety score 8. Insomnia Severity Index |
Key inclusion & exclusion criteria
Age minimum | >= 16age old |
---|---|
Age maximum | <= 75age old |
Gender | Both |
Include criteria | 1. Patients with IBS diagnosed with Rome IV criteria 2. Patients treated at the 1st step in clinical practice guideline of JSGE 2014 at least 4 weeks before randomization. 3. Condition with STAI-state score >= 41 4. Aged 16-75 years at the time of informed consent 5. Provision of written informed consent |
Exclude criteria | 1. Major abdominal surgery (except appendectomy or hysterectomy) 2. History of inflammatory bowel disease, ischemic colitis, malignant tumor 3. Severe neurological complications (Parkinson's disease, Shy-Drager syndrome, schizophrenia, bipolar disorder) 4. Use of Kampo within 4 weeks prior to randomization 5. Allergy to Kampo 6. Lactose intolerance 7. Allergy to Starch 8. Severe complications (hepatic diseases, serious cardiovascular diseases, hematological diseases, metabolic diseases or malignant neoplasms) 9. Pregnancy, breastfeeding or planning on becoming pregnant throughout the course of the study 10. Unable to take MRI 11. Lack of suitability for participation in the study for any reason as judged by the investigator |
Related Information
Primary Sponsor | Fukudo Shin |
---|---|
Secondary Sponsor | TSUMURA & CO. Ltd. |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Motoyori Kanazawa |
Address | 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan Miyagi Japan 980-8574 |
Telephone | +81-22-717-7327 |
m-kanazawa@med.tohoku.ac.jp | |
Affiliation | Tohoku University Hospital |
Scientific contact | |
Name | Shin Fukudo |
Address | 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan Miyagi Japan 980-8574 |
Telephone | +81-90-4885-6083 |
sfukudo@med.tohoku.ac.jp | |
Affiliation | Tohoku University Hospital |